AstraZeneca Pharma India Ltd. Share Price
8,483.50 +34.00 (+0.40%)Fundamentals
Market Cap₹21,230Cr | EPS₹46.30 |
Book Value/Share₹332.64 | P/E Ratio (TTM)105.15 |
Industry P/E (TTM)39.36 | P/B Ratio30.26 |
Long Term D/E0.05 | ROE17.30% |
Dividend Yield (TTM)0.40% |
Analysis
Overview
Key stock indicators that show how well a company is doing, making it easier to understand its true value and performance.
Strong Outperformer
Excellent Quality
Low Price Fluctuation
Peer Comparison
Peer comparison lists companies from the same sector, scored and ranked based on Crisp Analysis. It helps understand how a company stands against its competitors.
Shareholding Pattern
Shareholding pattern shows how a company’s shares (ownership) are distributed among different shareholding entities like promoters, Foreign Institutional Investors (FIIs), Domestic Institutional Investors (DIIs), and retail investors, among others. Changes in the shareholding pattern can indicate the performance outlook of a stock.
FAQs on AstraZeneca Pharma India Ltd.
The share price of AstraZeneca Pharma India Ltd. is ₹8,483.50 on NSE as of 19/3/2026, 5:55:31 am. Share prices may change frequently due to market movements.
The market capitalisation of AstraZeneca Pharma India Ltd. is ₹21,230Cr as of 19/3/2026, 5:55:31 am
The current Price to Earnings (P/E) ratio of AstraZeneca Pharma India Ltd. is 105.15 as of 19/3/2026, 5:55:31 am
The Price to Book (P/B) ratio of AstraZeneca Pharma India Ltd. stands at 30.26 as of 19/3/2026, 5:55:31 am
AstraZeneca Pharma India Ltd. reported an ROE of 17.31% for the last reported financial year on a consolidated account basis.
As of 19/3/2026, 5:55:31 am, AstraZeneca Pharma India Ltd.’s shareholding pattern is: promoters hold 75.00%, FIIs hold 2.70%, DIIs hold 5.60%, and public shareholders hold 16.70%.
The 52-week high of AstraZeneca Pharma India Ltd. is ₹8,591.00 and the 52-week low is ₹8,417.00 as of 19/3/2026, 5:55:31 am.
The earnings per share (EPS) of AstraZeneca Pharma India Ltd. is ₹13.04 for the quarter ended Dec 2025.
The stock symbol of AstraZeneca Pharma India Ltd. is ASTRAZEN.
You can buy AstraZeneca Pharma India Ltd. shares by opening a demat and trading account with Share.Market and placing a buy order on NSE or BSE during market hours.
The fair value of AstraZeneca Pharma India Ltd. depends on factors such as earnings growth, financial performance, and overall market conditions. Investors should assess fundamentals before making investment decisions.
Earnings Per Share
Earnings per share (EPS) measures the profit earned by a company for each of its outstanding shares. Generally, the higher a company’s EPS is, the more profitable it is considered to be.
Income Statement
Also called a profit and loss statement, an income statement shows a company’s income, expenses, and how much profit or loss it has made over a specific accounting period. It provides a clear view of how well the business is running.
| Particulars (in Cr) | Dec 2025 | Q/Q Change |
|---|---|---|
| Operating Revenue | 611.57 | +9.39% |
| Other Income | 5.13 | -16.86% |
| Total Income | 616.70 | +9.10% |
| Total Expenditure | 566.74 | +17.12% |
| EBIDT | 51.44 | -32.37% |
| Depreciation | 3.84 | +49.42% |
| Interest | 1.06 | +58.21% |
| Tax | 13.95 | -25.00% |
| Net Profit | 32.59 | -39.89% |
Balance Sheet
A balance sheet is a financial statement that details a company’s assets, liabilities, and shareholders’ equity at a given time. It helps assess how financially strong and stable the company is.
| Particulars (in Cr) | Mar 2025 |
|---|---|
| Total Current Assets | 1,342.35 |
| Total Non-Current Assets | 175.77 |
| Fixed assets | 64.24 |
| Total Assets | 1,518.12 |
| Total Current liabilities | 703.00 |
| Total Non Current Liabilities | 44.77 |
| Total Equity Plus Liabilities | 1,518.12 |
| Total Shareholder Funds | 770.35 |
| Total Debt to Equity | 0.00% |
Cash Flow
Cash flow highlights the cash or cash equivalents moving in and out of a company during a particular period. It provides a clear picture of how well a company manages its cash by tracking its operating, investing and financing activities.
| Particulars (in Cr) | Mar 2025 |
|---|---|
| Cash from Operating Activity | 65.36 |
| Cash from Financing Activities | -65.59 |
| Cash from Investing Activities | 30.80 |
| Net Cash Flow | 30.57 |
Time Period: Daily
SMA/EMA (Moving Average) Analysis
Bullish Moving Averages0
Bearish Moving Averages16
5 Day
8,519.0010 Day
8,608.5020 Day
8,736.5030 Day
8,756.0050 Day
8,603.50100 Day
8,870.10150 Day
8,882.80200 Day
8,970.80Indicators
RSI (14)
39.16MACD (12, 26)
-65.08MACD Signal Line (9)
-15.00MFI (14)
35.78ATR (14)
217.09ADX (14)
24.19ROC (21)
-5.26ROC (125)
-6.21Pivot Analysis
Pivot analysis uses a special price point, called the pivot point, to show the overall market trend during different periods. This pivot point is the average of the previous day’s high, low, and closing prices of a specific asset.
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 8,533.00 | 8,616.50 | 8,727.00 | 8,422.50 | 8,339.00 | 8,228.50 | 8,145.00 |
Note: Support and Resistance level for the day, calculated based on price range of the previous trading day.
Volume Analysis
Volume analysis tracks how many shares were traded for a specific period. Total traded volume represents the overall number of shares traded, while combined delivery volume indicates only those shares which are delivered (transferred for ownership). Delivered shares indicate long-term investor interest.
AstraZeneca Pharma India Ltd.
ASTRAZEN
Open Price | 8,465.00 |
Prev Close | 8,449.50 |
Upper Circuit | 10,139.00 |
Lower Circuit | 6,760.00 |
Volume | 3,712 |
Average Traded Price | 8,499.22 |